精锋医疗-B（02675）公布，公司将探究拟发行人民币股份的初步建议，启动在A股市场首次公开发行人民币普通股及上市的计划（建议A股上市）。建议发行人民币股份取决于及受限于（其中包括）市场状况、董事会的进一步批准、公司股东于股东大会上的批准及必要监管机构的批准。
就建议A股上市而言，公司已委聘上市前辅导机构，并于2026年9月11日提交上市前辅导的登记申请。于本公告日期，除本文所披露的资料外，董事会尚未批准有关建议A股上市的其他计划，亦未就建议A股上市向中国或任何其他地区的相关监管机构提出任何申请。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.